Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

13.50 USD +0.53 (+4.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 174,526
Open 13.18
Bid (Size) 13.26 (1)
Ask (Size) 13.85 (1)
Prev. Close 12.97
Today's Range 13.00 - 13.50
52wk Range 12.12 - 22.91
Shares Outstanding N/A
Dividend Yield 44.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
U.S. Is Dominating Psychedelic Drugs Market Due To Growing Acceptance For Treating Depression & Rise In Product Approvals
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert

Performance

YTD
-30.59%
-30.59%
1 Month
-11.13%
-11.13%
3 Month
-22.32%
-22.32%
6 Month
-30.59%
-30.59%
1 Year
-30.59%
-30.59%

More News

Read More
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder
From GlobeNewswire News Releases
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
From InvestorBrandNetwork
What Is Precision Psychiatry? Biotech Company Leverages New Approach To Mental Health Disorders
Tags Small Cap Benzinga PsyProtix
From Benzinga
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021
Tags Pharma/Biotech Stocks / Equities Market News
From TalkMarkets
Atai Life Launches Depression-Focused Firm
Tags General Benzinga Small Cap
From Benzinga
Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases
From InvestorBrandNetwork
Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery
Tags KTTA Partner Content Pasithea
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.